Ontology highlight
ABSTRACT: Background
Current bulk transcriptomic classification systems for bladder cancer do not consider the level of intratumor subtype heterogeneity.Objective
To investigate the extent and possible clinical impact of intratumor subtype heterogeneity across early and more advanced stages of bladder cancer.Design setting and participants
We performed single-nucleus RNA sequencing (RNA-seq) of 48 bladder tumors and additional spatial transcriptomics for four of these tumors. Total bulk RNA-seq and spatial proteomics data were available from the same tumors for comparison, along with detailed clinical follow-up of the patients.Outcome measurements and statistical analysis
The primary outcome was progression-free survival for non-muscle-invasive bladder cancer. Cox reg
SUBMITTER: Lindskrog SV
PROVIDER: S-EPMC10175738 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature